Ellen Liang
Internal Medicine · Flushing, NYNPI 1114000494
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (57.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Amgen accounts for 62.4% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2019 at $9,802 and has fallen 97.9% since, to $209 in 2023. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 288 payments — averaging $51.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$9K
- AbbVie$1K
- Nestle Healthcare Nutrition Inc.$810
- Gilead$759
- AstraZeneca$461
- Novartis$354
- plus $2K from 21 others
What the payments were for
- Speaking & faculty fees$8,40057%
- Travel & lodging$1191%
- Food & beverage$6,17242%
- Education$590%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 46 | $9,203 |
| AbbVie(2 entities) | 46 | $1,161 |
| Nestle Healthcare Nutrition Inc. | 35 | $810 |
| Gilead | 27 | $759 |
| AstraZeneca(2 entities) | 32 | $461 |
| Novartis | 18 | $354 |
| Novo Nordisk | 15 | $308 |
| Amarin Pharma, Inc. | 8 | $280 |
| Lilly USA, LLC | 10 | $186 |
| QOL Medical, LLC | 7 | $183 |
| Biogen | 8 | $162 |
| Insmed, Inc. | 1 | $125 |
| Intra-sana Laboratories | 2 | $120 |
| GSK | 5 | $118 |
| Hikma Pharmaceuticals USA | 5 | $99 |
| Redhill Biopharma Inc. | 4 | $88 |
| Pfizer | 5 | $69 |
| Bayer | 2 | $54 |
| Eyevance Pharmaceuticals LLC | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Daiichi Sankyo Inc. | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $22 |
| Radius Health, Inc. | 1 | $21 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Boehringer Ingelheim | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,750 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Other internal medicine in Flushing
- Weining LiangFlushing$133K
- David DoveEast Hampton$12.3M
- Bruce BergerBrooklyn$3.4M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
- Javier MoralesGreenvale$1.3M
- Ricky HsuNew York$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.